SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001178031-11-000004
Filing Date
2011-05-18
Accepted
2011-05-18 16:51:10
Documents
2
Period of Report
2011-05-18

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 1467
2 POA poasnyderman.txt EX-24 3465
  Complete submission text file 0001178031-11-000004.txt   6316
Mailing Address 929 NORTH FRONT STREET WILMINGTON NC 28401
Business Address 929 NORTH FRONT STREET WILMINGTON NC 28401 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Issuer) CIK: 0001003124 (see all company filings)

IRS No.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address C/O SAIC 10260 CAMPUS POINT DR M/S F3 SAN DIEGO CA 92121
Business Address
SNYDERMAN RALPH (Reporting) CIK: 0001178031 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-27570 | Film No.: 11855383